Ameriprise’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-568,953
| Closed | -$48.3M | – | 3805 |
|
|
2019
Q4 | $48.3M | Sell |
568,953
-206,618
| -27% | -$13.8M | 0.02% | 718 |
|
|
2019
Q3 | $38.8M | Sell |
775,571
-7,601
| -1% | -$303K | 0.02% | 781 |
|
|
2019
Q2 | $28.6M | Buy |
783,172
+21,164
| +3% | +$691K | 0.01% | 940 |
|
|
2019
Q1 | $21.3M | Buy |
762,008
+45,895
| +6% | +$1.08M | 0.01% | 1082 |
|
|
2018
Q4 | $13.7M | Sell |
716,113
-37,132
| -5% | -$864K | 0.01% | 1333 |
|
|
2018
Q3 | $22.5M | Buy |
753,245
+212,648
| +39% | +$8.01M | 0.01% | 1204 |
|
|
2018
Q2 | $19.8M | Buy |
540,597
+23,816
| +5% | +$774K | 0.01% | 1178 |
|
|
2018
Q1 | $17M | Buy |
516,781
+43,826
| +9% | +$1.37M | 0.01% | 1239 |
|
|
2017
Q4 | $12.9M | Buy |
472,955
+37,439
| +9% | +$1.15M | 0.01% | 1401 |
|
|
2017
Q3 | $16.1M | Buy |
435,516
+16,943
| +4% | +$625K | 0.01% | 1210 |
|
|
2017
Q2 | $15.9M | Sell |
418,573
-23,500
| -5% | -$1.05M | 0.01% | 1189 |
|
|
2017
Q1 | $21.6M | Buy |
442,073
+88,542
| +25% | +$4.04M | 0.01% | 962 |
|
|
2016
Q4 | $12M | Buy |
353,531
+4,409
| +1% | +$156K | 0.01% | 1379 |
|
|
2016
Q3 | $13.2M | Buy |
349,122
+10,065
| +3% | +$379K | 0.01% | 1226 |
|
|
2016
Q2 | $11.4M | Buy |
339,057
+14,662
| +5% | +$517K | 0.01% | 1285 |
|
|
2016
Q1 | $10.3M | Buy |
324,395
+3,696
| +1% | +$121K | 0.01% | 1386 |
|
|
2015
Q4 | $12M | Sell |
320,699
-38,924
| -11% | -$1.47M | 0.01% | 1308 |
|
|
2015
Q3 | $13.7M | Buy |
359,623
+45,227
| +14% | +$1.59M | 0.01% | 1211 |
|
|
2015
Q2 | $8.99M | Buy |
314,396
+7,642
| +2% | +$213K | 0.01% | 1691 |
|
|
2015
Q1 | $8.6M | Buy |
306,754
+14,877
| +5% | +$418K | ﹤0.01% | 1681 |
|
|
2014
Q4 | $8.08M | Buy |
291,877
+7,256
| +3% | +$180K | ﹤0.01% | 1685 |
|
|
2014
Q3 | $6.35M | Buy |
284,621
+11,142
| +4% | +$283K | ﹤0.01% | 1857 |
|
|
2014
Q2 | $7.95M | Buy |
273,479
+12,064
| +5% | +$322K | ﹤0.01% | 1729 |
|
|
2014
Q1 | $7.43M | Buy |
261,415
+7,851
| +3% | +$260K | ﹤0.01% | 1762 |
|
|
2013
Q4 | $9.79M | Buy |
253,564
+13,352
| +6% | +$477K | 0.01% | 1520 |
|
|
2013
Q3 | $8.05M | Buy |
240,212
+31,178
| +15% | +$993K | 0.01% | 1615 |
|
|
2013
Q2 | $6.43M | Buy |
+209,034
| New | +$6.99M | ﹤0.01% | 1733 |
|
Other funds holding MDCO
Ameriprise's MDCO Position: Q1 2020 in Review
Ameriprise sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 568,953 shares — an estimated $48.3M sold.
Ameriprise first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $48.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Ameriprise reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Ameriprise sold 568,953 Medicines Co shares in Q1 2020, an estimated $48.3M.
- Ameriprise first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Ameriprise's Medicines Co position peaked at $48.3M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Ameriprise's 13F filing for Q1 2020, filed 15 May 2020.